ThePigSite Latest News
Boar Taint Prevention Vaccine Launched in Europe
EUROPE - A vaccine that could spell the end of boar taint in pork was launched in Europe this week by pharmaceutical company Pfizer.
The vaccine, Improvac, which was developed initially in Australia and has been on the Australian and South East Asian markets for a number of years removes the need to castrate pigs to prevent boar taint.
The vaccine is being produced for the European market in the Pfizer laboratories in Belgium.
The vaccine, which has to be delivered twice to male pigs prevents temporarily interrupts the testicular function reducing the level the compounds that produce boar taint - androstenone and skatole.
Pfizer says the vaccine is welfare friendly as it avoids the need for castration and it also has benefits for better growth performance and feed conversion. By suppressing the hormone activity, the pigs are also calmer and less likely to bite one another.
The vaccine has yet to be approved by the US authorities.
| ThePigSite News Desk | Read more Pfizer Animal Health News here |
Related news items:
Biosecurity Benchmarking Study to Be Launched
OIE Reports New ASF Outbreak in Russia
Commission to Tackle Anti-Microbial Resistance
NPPC Urges Equal Billing for Pork Industry Workers
Call for Govt to Act over Antibiotic Resistance
Related News Categories: Pig Health, Pig Welfare, Pig Meat Quality
More of the latest Pig Industry News
Interest in US Feed Grains Grows in Viet Nam- Biosecurity Benchmarking Study to Be Launched
- Tyson Foods Names New Top Executives
WTO Investigates Poultry, Livestock Complaints- OIE Reports New ASF Outbreak in Russia
- UK Slaughter Statistics - November 2009
- CME: Drop in Pork Prices Seen in October
Taiwanese Nutritionists Learn About DDGS- Commission to Tackle Anti-Microbial Resistance
VIV China Reflects Development of Chinese Industry
